Home›Companies›Biotech & Pharma›Neumentum

Neumentum, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 28, 2023·Suggest an edit

About Neumentum

Neumentum is a private company based in Summit, New Jersey. It has reported $32,502,757 raised in five offerings on Form D since October 2017.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 30, 2021Oct 14, 2021amended Apr 28, 2023$16,559,757of $20.0M target33$501KEquityRule 506(b)Form D/A ↗2 earlier filings
Nov 1, 2019Nov 15, 2019$2,663,000of $7.0M target18$147KDebt, OptionsRule 506(b)Form D ↗
Mar 12, 2019Mar 27, 2019amended Sep 6, 2019$3,020,000of $7.0M target36$83,889Debt, OptionsRule 506(b)Form D/A ↗1 earlier filing
May 14, 2018May 25, 2018$5,000,000of $10.0M target38$131KEquityRule 506(b)Form D ↗
Oct 24, 2017Oct 31, 2017$5,260,000of $6.0M target53$99,245EquityRule 506(b)Form D ↗
Total, five offerings$32,502,757

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Neumentum's Form D filed Apr 28, 2023.

TM
Taggart McGurrin
Executive officer
JP
Joseph Pergolizzi
Director
Also a president & CEO, director at Native Cardio.
AM
AB
Andrew Blank
Director

Earlier filings also listed Richard Shively (executive officer, last listed Nov 2019), Pedro Granadillo (director, last listed Nov 2019), Ilona Steigerwald (executive officer, last listed Nov 2019) and Christine Cvijic (executive officer and director, last listed Nov 2019).

Sources

  1. SECNeumentum, Inc. Form D/A, filed Oct 21, 2021
  2. SECNeumentum, Inc. Form D, filed Oct 14, 2021
  3. SECNeumentum, Inc. Form D, filed Mar 27, 2019
  4. SECNeumentum, Inc. filing history